CAS 839712-25-3
:Ureia, [trans-4-[2-[4-(2,3-diclorofenil)-1-piperazinil]etil]cicloexil]-
Didesmethyl Cariprazine
CAS:Produto ControladoApplications Didesmethyl Cariprazine, s a derivative of Cariprazine (C183490) which is an orally active D2/D3 dopamine receptor antagonist (1,2,3). Cariprazine is an antipsychotic drug candidate for the potential treatment of schizophrenia, bipolar mania and depression.
References Gruender, G.: Curr. Opin. Invest. Drugs, 11, 823 (2010); Seneca, N. et al.: Psychopharmacology, 218, 579 (2011); Kiss, B. et al.: J. Pharmacol. Exp. Therap., 333, 328 (2010)Fórmula:C19H28Cl2N4OCor e Forma:NeatPeso molecular:399.36Didesmethyl cariprazine
CAS:Didesmethyl cariprazine is a peptide that belongs to the group of activators. It has been shown to be an inhibitor of protein interactions and a ligand for the 5-HT2A receptor. Didesmethyl cariprazine has also been found to have pharmacological effects on ion channels and cell biology, such as life science.
Fórmula:C19H28Cl2N4OPureza:Min. 95%Peso molecular:399.4 g/molDidesmethyl cariprazine
CAS:Didesmethyl cariprazine, Cariprazine's active metabolite, treats schizophrenia/bipolar with D3/D2 affinity; half-life 1-3 weeks.Fórmula:C19H28Cl2N4OPureza:99.52%Cor e Forma:SolidPeso molecular:399.36





